Published in Clin Exp Immunol on September 01, 1981
Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest (1985) 3.40
Serum levels of interferons in patients with systemic lupus erythematosus. Clin Exp Immunol (1987) 1.76
Interferon-induced 2'-5' adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon. J Exp Med (1983) 1.18
Endogenous and interferon-augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro. Studies of patients with multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis. Clin Exp Immunol (1982) 1.14
Natural killer cells and interferon responses in patients with systemic lupus erythematosus. Clin Exp Immunol (1982) 0.99
Natural killer cell in systemic lupus erythematosus. Defects in effector lytic activity and response to interferon and interferon inducers. J Clin Invest (1983) 0.96
A sensitive radioimmunoassay for alpha-interferon: circulating alpha-interferon-like substance in the plasma of healthy individuals and rheumatoid arthritis patients. Clin Exp Immunol (1986) 0.96
Reduced killer cell activity of lymphocytes from patients with asbestosis. Br J Ind Med (1985) 0.88
Interferon deficiency syndrome. Clin Exp Immunol (1985) 0.85
Natural killer cell activity in Sjögren's syndrome and systemic lupus erythematosus: stimulation with interferons and interleukin-2 and correlation with immune complexes. Ann Rheum Dis (1990) 0.82
Tumour necrosis factor (TNF) production by T cell receptor-primed T lymphocytes is a target for low dose methotrexate in rheumatoid arthritis. Clin Exp Immunol (1999) 0.81
Synthesis of intrathecal interferon in systemic lupus erythematosus with neurological complications. Br Med J (Clin Res Ed) (1983) 0.79
Increased activity of oligo-2',5'-adenylate synthetase in Down's syndrome and epilepsy. Clin Exp Immunol (1987) 0.79
Fate of herpes simplex virus in lymphocytes from blood and joint effusions of systemic and pauciarticular juvenile chronic arthritis. Ann Rheum Dis (1983) 0.75
1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis (1958) 24.41
Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med (1979) 5.58
Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus. J Clin Invest (1977) 5.09
Immunoregulatory aberrations in systemic lupus erythematosus. J Immunol (1978) 3.07
Mechanisms of activation of human natural killer cells against tumor and virus-infected cells. Immunol Rev (1979) 1.88
Depression of cellular-mediated immunity in systemic lupus erythematosus. relation to disease activity. Arthritis Rheum (1975) 1.73
Absence of virus-induced lymphocyte suppression and interferon production in multiple sclerosis. Proc Natl Acad Sci U S A (1979) 1.47
Time and dosage dependence of immunoenhancement by murine type II interferon preparations. Cell Immunol (1978) 1.43
Decreased 19S antibody response to bacterial antigens in systemic lupus erythematosus. J Clin Invest (1969) 1.43
Natural killer funciton in systemic lupus erythematosus. Arthritis Rheum (1980) 1.41
Interferon as a mediator of human lymphocyte suppression. J Exp Med (1980) 1.25
Mitogen and antigen induction of interferon in vitro and in vivo. Tex Rep Biol Med (1977) 1.19
Target cells for interferon production in human leukocytes stimulated by sendai virus. J Immunol (1977) 1.15
Human T-lymphocyte subpopulations: alterations in systemic lupus erythematosus. Scand J Immunol (1979) 1.04
Interferon production by human leucocytes in vitro. Reduced levels in lymphatic leukemia. Proc Soc Exp Biol Med (1966) 0.96
Interferon production by lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum (1974) 0.89
Leukocyte interferon production, RNA synthesis, and PHA response in patients with infectious mononucleosis. Blood (1973) 0.83
In vitro leukocyte interferon production in patients with Hodgkin's disease. Cancer Res (1974) 0.81
The stimulation of globin synthesis by heme. Proc Natl Acad Sci U S A (1966) 1.86
Rubella infection of synovial cells and the resistance of cells derived from patients with rheumatoid arthritis. J Exp Med (1970) 1.48
Absence of virus-induced lymphocyte suppression and interferon production in multiple sclerosis. Proc Natl Acad Sci U S A (1979) 1.47
Effect of long-term normalization of serum complement levels on the course of lupus nephritis. Am J Med (1989) 1.43
THE RENAL EXCRETION OF URIC ACID IN GOUT. J Clin Invest (1962) 1.23
Pericardial tamponade in systemic lupus erythematosus; with absent hemolytic complement activity in pericardial fluid. N Y State J Med (1975) 1.14
Endogenous and interferon-augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro. Studies of patients with multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis. Clin Exp Immunol (1982) 1.14
A cytotoxic proteinase isolated from human lymphocytes. J Immunol (1978) 1.05
Interferon responses of leukocytes in multiple sclerosis. Neurology (1981) 1.04
Simultaneous gout, pseudogout, and septic arthritis. Arthritis Rheum (1980) 1.02
Uridine incorporation into the media and RNA of cultured rheumatoid synovial cells. Arthritis Rheum (1973) 1.01
The role of heme in the synthesis and assembly of hemoglobin. J Biol Chem (1968) 1.01
The effect of normalization of serum complement and anti-DNA antibody on the course of lupus nephritis: a two year prospective study. Am J Med (1978) 1.01
Susceptibility of mice to acute and persistent measles infection. Infect Immun (1978) 1.00
Nitrogen mustard: an "in vitro" inhibitor of erythrocyte sickling. Biochem Biophys Res Commun (1972) 0.99
Protease activity of normal and PHA stimulated human lymphocytes. Cell Immunol (1975) 0.99
Murine cytomegalovirus and fertility: potential sexual transmission and the effect of this virus on fertilization in vitro. Fertil Steril (1978) 0.93
Effects of inhibitors of protein synthesis on the synthesis of heme in rabbit reticulocytes. Biochem Biophys Res Commun (1967) 0.92
Suppression of anti-DNA antibody synthesis in vitro by a cross-reactive antiidiotypic antibody. J Clin Invest (1987) 0.92
Human large granular lymphocytes and natural killing ultrastructural studies of strontium-induced degranulation. Eur J Immunol (1982) 0.92
Studies on the susceptibility of the mouse preimplantation embryo to infection with cytomegalovirus. J Reprod Fertil (1978) 0.90
Sr++-induced inhibition of human natural killer (NK) cell-mediated cytotoxicity. J Immunol (1982) 0.90
A factor promoting the initiation of globin synthesis in a rabbit reticulocyte cell-free system. Proc Natl Acad Sci U S A (1969) 0.89
Immunogenic potentials of copolymer I in normal human lymphocytes. Neurology (1985) 0.88
Persistence of pneumococcal antibodies after immunization in patients with systemic lupus erythematosus. J Rheumatol (1984) 0.86
Brachial plexus neuropathy as the initial presentation of systemic lupus erythematosus. Neurology (1979) 0.86
Pulmonary dysfunction in systemic lupus erythematosus:prevalence classification and correlation with other organ involvement. J Rheumatol (1980) 0.85
Immunological studies in senile dementia of the Alzheimer type: evidence for enhanced suppressor cell activity. Ann Neurol (1981) 0.85
The effect of continuous normalization of serum hemolytic complement on the course of lupus nephritis: a five year prospective study. Am J Med (1981) 0.84
Chronic polyarthritis associated with hypogammaglobulinemia. A study of two patients. Arthritis Rheum (1977) 0.84
Central nervous system systemic lupus erythematosus versus central nervous system infection: low cerebral spinal fluid glucose and pleocytosis in a patient with a prolonged course. Arthritis Rheum (1982) 0.82
The control of hemoglobin synthesis. Trans Assoc Am Physicians (1967) 0.81
Impaired response to pneumococcal vaccine in systemic lupus erythematosus. Arthritis Rheum (1980) 0.81
Natural killer cell activity of mononuclear cells from rheumatoid patients measured by a conjugate-binding cytotoxicity assay. Arthritis Rheum (1982) 0.79
Studies of interferon production and natural killing by lymphocytes from multiple sclerosis patients. Ann N Y Acad Sci (1984) 0.79
Acquired antithrombin III deficiency and systemic lupus erythematosus. Ann Rheum Dis (1981) 0.78
Psychologically distinguishable groups of rheumatoid arthritis patients: a controlled, single blind study. Psychosom Med (1982) 0.78
The growth of vaccine strains of rubella virus in cultured human synovial cells. Proc Soc Exp Biol Med (1971) 0.78
The immunoglobulin class of anti-DNA antibodies: detection by a fluorometric immunoassay: clinical and pathological correlations in SLE. J Rheumatol (1978) 0.76
Magnetic resonance imaging versus computed tomographic scanning in neuropsychiatric systemic lupus erythematosus. Am J Med (1989) 0.76
Potassium cyanate, an in vitro inhibitor of lymphocyte blast transformation without in vivo activity. Proc Soc Exp Biol Med (1976) 0.75
Cold urticaria and an oral contraceptive. Ann Intern Med (1983) 0.75
Activation of cyclophosphamide by liver cell cultures. Biochem Pharmacol (1975) 0.75
The effect of serum from patients with systemic lupus erythematosus on the immune response of normal lymphocytes. J Rheumatol (1985) 0.75
Measurement of complement components in systemic lupus erythematosus by radial immunodiffusion. Am J Clin Pathol (1977) 0.75
The role of arthroscopy in the treatment of septic arthritis. Arthritis Rheum (1981) 0.75
Markers and subsets--clue to pathogenesis in systemic lupus erythematosus? Br J Rheumatol (1988) 0.75
Copolymer I: effect on normal human lymphocytes. Ann N Y Acad Sci (1984) 0.75
The effect of maternal cytomegalovirus infection on preimplantation development in the mouse. J Reprod Fertil (1976) 0.75
A lupus antibody syndrome associated with hypernephroma. Arthritis Rheum (1979) 0.75
Bilateral total knee replacement in a patient with sickle cell disease. Clin Orthop Relat Res (1974) 0.75